ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for CCCC

Stock NameC4 Therapeutics Inc
TickerCCCC(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS12529R1077

Show aggregate CCCC holdings

News associated with CCCC

C4 Therapeutics (NASDAQ:CCCC) Coverage Initiated by Analysts at Barclays
Analysts at Barclays began coverage on shares of C4 Therapeutics (NASDAQ:CCCC – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $8.00 price target on the stock. Barclays‘s target price would indicate a potential upside of 140.96% from the company’s previous close. Other equities […] - 2025-09-19 02:50:58
C4 Therapeutics (NASDAQ:CCCC) Stock Rating Upgraded by Stephens
C4 Therapeutics (NASDAQ:CCCC – Get Free Report) was upgraded by equities researchers at Stephens from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, MarketBeat.com reports. The firm presently has a $6.00 price objective on the stock, up from their prior price objective of $3.00. Stephens’ target price points […] - 2025-09-17 02:46:43
Analysts Set C4 Therapeutics, Inc. (NASDAQ:CCCC) Target Price at $8.00
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) has earned a consensus rating of “Hold” from the five analysts that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among analysts that […] - 2025-09-09 02:46:49
C4 Therapeutics (NASDAQ:CCCC) Downgraded by Wall Street Zen to “Sell”
C4 Therapeutics (NASDAQ:CCCC – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. C4 Therapeutics Trading Down 3.1% Shares of NASDAQ CCCC opened at $2.50 on Friday. The stock has a market cap of $177.52 million, a P/E ratio of […] - 2025-08-11 04:32:55
Rhumbline Advisers Trims Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Rhumbline Advisers reduced its stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 10.4% during the 1st quarter, HoldingsChannel reports. The fund owned 89,633 shares of the company’s stock after selling 10,382 shares during the period. Rhumbline Advisers’ holdings in C4 Therapeutics were worth $143,000 at the end of the most recent […] - 2025-06-26 04:54:51
Hennion & Walsh Asset Management Inc. Lowers Stake in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Hennion & Walsh Asset Management Inc. reduced its stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 3.8% in the first quarter, Holdings Channel reports. The firm owned 218,411 shares of the company’s stock after selling 8,736 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in C4 Therapeutics were […] - 2025-06-09 06:10:59
Millennium Management LLC Has $1.30 Million Stock Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Millennium Management LLC lifted its position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 1,548.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 360,125 shares of the company’s stock after acquiring an additional 338,277 shares during the period. Millennium Management LLC’s […] - 2025-06-05 04:32:55
ProShare Advisors LLC Raises Stock Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC)
ProShare Advisors LLC increased its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 83.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 20,283 shares of the company’s stock after acquiring an additional 9,204 shares during the period. ProShare Advisors LLC’s holdings in C4 Therapeutics were worth $73,000 at the end […] - 2025-06-04 04:58:51
C4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Sold by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. lessened its position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 35.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,479 shares of the company’s stock after selling 42,413 shares during the […] - 2025-05-28 04:40:51
Two Sigma Advisers LP Sells 181,200 Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC)
Two Sigma Advisers LP lessened its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 17.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 884,300 shares of the company’s stock after selling 181,200 shares during the period. Two Sigma Advisers LP’s holdings in C4 Therapeutics were worth $3,183,000 at the […] - 2025-05-27 05:15:08
Lazard Asset Management LLC Purchases New Shares in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Lazard Asset Management LLC bought a new position in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 22,693 shares of the company’s stock, valued at approximately $81,000. Other institutional investors have also recently made changes to […] - 2025-05-26 04:48:53
Mariner LLC Has $605,000 Stake in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Mariner LLC increased its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 28.8% during the fourth quarter, Holdings Channel reports. The fund owned 167,975 shares of the company’s stock after acquiring an additional 37,564 shares during the quarter. Mariner LLC’s holdings in C4 Therapeutics were worth $605,000 as of its most […] - 2025-05-01 05:19:12
Bank of Montreal Can Has $88,000 Position in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Bank of Montreal Can decreased its stake in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 54.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 24,450 shares of the company’s stock after selling 29,666 shares during the period. Bank of Montreal Can’s holdings in C4 Therapeutics were worth $88,000 at the end of […] - 2025-04-27 05:26:58
C4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Acquired by M&T Bank Corp
M&T Bank Corp grew its stake in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 16.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 132,715 shares of the company’s stock after acquiring an additional 18,808 shares during the quarter. M&T Bank Corp’s holdings […] - 2025-03-14 06:08:51
Financial Contrast: C4 Therapeutics (NASDAQ:CCCC) and Fennec Pharmaceuticals (NASDAQ:FENC)
Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) and C4 Therapeutics (NASDAQ:CCCC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership. Valuation & Earnings This table compares Fennec […] - 2025-02-20 05:06:47
China Universal Asset Management Co. Ltd. Acquires New Shares in C4 Therapeutics, Inc. (NASDAQ:CCCC)
China Universal Asset Management Co. Ltd. acquired a new stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 14,967 shares of the company’s stock, valued at approximately $54,000. Other hedge funds also […] - 2025-02-04 06:53:04

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) CCCC holdings

DateNumber of CCCC Shares HeldBase Market Value of CCCC SharesLocal Market Value of CCCC SharesChange in CCCC Shares HeldChange in CCCC Base ValueCurrent Price per CCCC Share HeldPrevious Price per CCCC Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CCCC by Blackrock for IE00BYXG2H39

Show aggregate share trades of CCCC

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY3482.2802.380 2.370USD 825 2.25
2025-10-03BUY8122.2702.330 2.324USD 1,887 2.25
2025-10-02BUY1162.2102.270 2.264USD 263 2.25
2025-09-30BUY2322.2202.249 2.246USD 521 2.25
2025-09-26BUY2322.2302.265 2.262USD 525 2.25
2025-09-25BUY2322.1902.420 2.397USD 556 2.25
2025-09-24BUY12.4202.625 2.605USD 3 2.25
2025-09-18BUY1153.3203.580 3.554USD 409 2.24
2025-09-17BUY3483.3803.470 3.461USD 1,204 2.23
2025-09-11SELL-1162.7302.750 2.748USD -319 2.21 Loss of -62 on sale
2025-09-10BUY2322.6402.690 2.685USD 623 2.21
2025-09-05SELL-1162.7202.850 2.837USD -329 2.20 Loss of -74 on sale
2025-08-29SELL-3482.6002.610 2.609USD -908 2.19 Loss of -145 on sale
2025-08-27BUY2322.5802.610 2.607USD 605 2.19
2025-08-26SELL-1162.5702.615 2.611USD -303 2.19 Loss of -49 on sale
2025-08-25BUY1162.5302.670 2.656USD 308 2.18
2025-08-20SELL-4642.6002.790 2.771USD -1,286 2.18 Loss of -275 on sale
2025-08-18BUY2322.8603.065 3.045USD 706 2.17
2025-08-08SELL-2322.5002.940 2.896USD -672 2.16 Loss of -170 on sale
2025-08-05BUY1162.0102.130 2.118USD 246 2.16
2025-08-01SELL-3452.1202.190 2.183USD -753 2.16 Loss of -7 on sale
2025-07-30BUY4602.1602.345 2.327USD 1,070 2.16
2025-07-17SELL-2322.1802.260 2.252USD -522 2.16 Loss of -22 on sale
2025-07-11SELL-9282.2302.410 2.392USD -2,220 2.16 Loss of -218 on sale
2025-07-07BUY3481.5201.530 1.529USD 532 2.17
2025-07-02BUY6,3251.5201.533 1.532USD 9,688 2.18
2025-06-25BUY2301.5401.570 1.567USD 360 2.21
2025-06-11BUY2301.5201.595 1.588USD 365 2.27
2025-06-10BUY2301.5701.715 1.701USD 391 2.28
2025-06-04SELL-1151.5401.565 1.563USD -180 2.30 Profit of 85 on sale
2025-04-23BUY1151.6101.740 1.727USD 199 2.63
2025-04-10SELL-9201.2101.330 1.318USD -1,213 2.82 Profit of 1,382 on sale
2025-04-08SELL-1151.2051.450 1.426USD -164 2.87 Profit of 166 on sale
2025-04-07SELL-1151.3301.340 1.339USD -154 2.89 Profit of 179 on sale
2025-04-04SELL-5751.3101.370 1.364USD -784 2.92 Profit of 894 on sale
2025-04-01BUY4601.4351.596 1.580USD 727 2.97
2025-03-31SELL-3451.6001.730 1.717USD -592 2.99 Profit of 439 on sale
2025-03-14SELL-1,8402.0302.070 2.066USD -3,801 3.21 Profit of 2,100 on sale
2025-03-07SELL-2302.3602.450 2.441USD -561 3.33 Profit of 204 on sale
2025-03-04SELL-1152.3802.400 2.398USD -276 3.40 Profit of 115 on sale
2025-02-25BUY2302.7902.900 2.889USD 664 3.51
2025-02-19SELL-1153.0103.095 3.087USD -355 3.58 Profit of 57 on sale
2025-02-13BUY3453.2003.375 3.358USD 1,158 3.65
2025-02-12BUY1153.3003.320 3.318USD 382 3.66
2025-02-11BUY4603.2703.340 3.333USD 1,533 3.67
2025-01-17BUY4603.9404.010 4.003USD 1,841 3.77
2025-01-16BUY4603.8604.030 4.013USD 1,846 3.76
2025-01-10SELL-2303.6653.795 3.782USD -870 3.78 Loss of 0 on sale
2025-01-08SELL-4603.8403.880 3.876USD -1,783 3.66 Loss of -99 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CCCC

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1980,3161,127381,50521.1%
2025-09-18326,50636,159698,63946.7%
2025-09-17203,286404758,05326.8%
2025-09-16260,5108,1821,036,61725.1%
2025-09-151,353,44325,9815,147,83726.3%
2025-09-1279,2551,000265,16029.9%
2025-09-1170,808719459,27015.4%
2025-09-1076,039105323,46523.5%
2025-09-0979,3130382,76320.7%
2025-09-08103,862200601,38617.3%
2025-09-0581,1811,943775,72610.5%
2025-09-04177,2217,000838,10821.1%
2025-09-0353,1632,182673,9267.9%
2025-09-02114,9734,800360,36131.9%
2025-08-29218,1580486,97644.8%
2025-08-28124,0000402,54430.8%
2025-08-2746,546603154,62330.1%
2025-08-26152,6480354,91043.0%
2025-08-2598,151897282,03934.8%
2025-08-2258,5080470,86212.4%
2025-08-2149,2866,165217,25622.7%
2025-08-20283,22021,676827,08734.2%
2025-08-19126,383600620,36720.4%
2025-08-18513,36362,124,23924.2%
2025-08-15125,539184617,55220.3%
2025-08-14107,90721519,45120.8%
2025-08-13109,0423,204680,46216.0%
2025-08-12141,98623,686506,03028.1%
2025-08-11428,38331,887883,89348.5%
2025-08-08627,3475,0841,762,37435.6%
2025-08-071,484,02213,8736,097,88424.3%
2025-08-06100,9870270,98837.3%
2025-08-05130,0010303,59242.8%
2025-08-04174,7156605,42428.9%
2025-08-0188,1863,900316,16227.9%
2025-07-31114,7820230,30049.8%
2025-07-30184,7500453,27740.8%
2025-07-29148,7270389,87738.1%
2025-07-2892,1080212,97243.2%
2025-07-25129,614324260,97549.7%
2025-07-24305,1636,043636,82347.9%
2025-07-23195,4531,086683,71328.6%
2025-07-22109,6041,731358,59730.6%
2025-07-21363,1500728,31249.9%
2025-07-18819,1252,2922,112,35138.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy